Drug Safety Associate I
Corbus Pharmaceuticals · Norwood, MA ·
- Work mode
- Hybrid
- Category
- Healthcare
Corbus Pharmaceuticals is building its first in-house pharmacovigilance team to support a growing late-stage portfolio. The Drug Safety Associate I will serve as the primary ICSR case processor, managing end-to-end intake and data entry in Veeva Vault Safety and ensuring expedited regulatory submissions meet ICH E2B and FDA/EMA timelines. This is a hands-on operational role ideal for a new-to-industry scientist eager to build deep PV expertise in a high-growth biotech setting. This is a hybrid role to Norwood, Ma requiring 3 days on site and 2 days remote weekly.
KEY RESPONSIBILITIES
Case Processing & Data Entry:
- Receive, triage, and process all incoming ICSRs — spontaneous, clinical trial, and literature — in Veeva Vault Safety.
- Perform MedDRA and WHODrug coding for adverse events, indications, and suspect/concomitant medications.
- Assess case seriousness, expectedness (per current IB/SmPC), and causality against source documents.
- Author or draft initial case narratives in accordance with ICH E2B(R3) and company SOPs.
- Submit 7-day and 15-day expedited ICSRs to FDA, EMA, and other applicable health authorities within regulatory timelines.
Database & Data Integrity:
- Maintain accurate and complete case records in Veeva Vault Safety; apply quality checks before lock.
- Execute follow-up requests to clinical sites, reporters, and CROs for missing or incomplete case information.
- Support migration of legacy CSPC safety data (~260 cases across 4 studies) into Vault Safety.
- Reconcile cases against Veeva EDC and partner safety databases as required.
Regulatory & Compliance Support:
- Assist in preparation of line listings and case data extracts for DSURs and PBRERs.
- Contribute to SOP authoring and maintenance as PV processes are established in-house.
- Participate in audit and inspection readiness activities; retrieve case documentation as requested.
- Support periodic reconciliation activities with CRO and clinical partners.